• Thumbnail for Anakinra
    Anakinra, sold under the brand name Kineret, is a biopharmaceutical medication used to treat rheumatoid arthritis, cryopyrin-associated periodic syndromes...
    24 KB (2,070 words) - 07:13, 15 March 2024
  • prednisone. Medications that block the action of interleukin-1, such as anakinra, can be effective treatments when standard steroid treatments are insufficient...
    17 KB (1,757 words) - 08:18, 25 August 2024
  • considered an autoinflammatory disorder and is generally treated with anakinra, which inhibits interleukin 1. This treatment controls the condition but...
    12 KB (1,235 words) - 02:56, 8 July 2024
  • Thumbnail for Interleukin-1 receptor antagonist
    antagonist called anakinra is used in the treatment of rheumatoid arthritis, an autoimmune disease in which IL-1 plays a key role. Anakinra differs from native...
    12 KB (1,323 words) - 14:55, 7 September 2024
  • Thumbnail for Mevalonate kinase deficiency
    can be used to reduce the effects of the disorder. Anakinra is antagonist to IL-1 receptors. Anakinra binds the IL-1 receptor, preventing the actions of...
    17 KB (1,951 words) - 05:41, 1 September 2024
  • Thumbnail for Cold urticaria
    they quit their job as a consequence of their disease". Treatment using anakinra (Kineret) has been shown effective for FCAS, although this does mean daily...
    23 KB (2,552 words) - 12:43, 12 September 2024
  • it. It should not be used in combination with anakinra or TNF antagonists. Because abatacept, anakinra, and TNF antagonists suppress the immune system...
    9 KB (850 words) - 19:46, 17 July 2024
  • Thumbnail for Hemophagocytic lymphohistiocytosis
    Commissioning Policy: Anakinra for Haemophagocytic Lymphohistiocytosis (HLH) for adults and children in all ages, allowing Anakinra (a modified recombinant...
    29 KB (3,295 words) - 09:07, 13 June 2024
  • Thumbnail for Interleukin 1 beta
    neurotoxic effect. Anakinra is a recombinant and slightly modified version of the human interleukin 1 receptor antagonist protein. Anakinra blocks the biologic...
    26 KB (3,273 words) - 13:58, 26 August 2024
  • Thumbnail for Systemic-onset juvenile idiopathic arthritis
    drugs, such as tocilizumab, and anti-interleukin-1 medications, such as anakinra, canakinumab, or rilonacept, are highly successful in managing the disease's...
    38 KB (3,740 words) - 22:17, 30 August 2024